Medicines the European Medicines Agency has recommended for use in the European Union on this topic.
Each number has its full source under its own list below.
86 medicines (authorised now). Newest first. Each links to its EMA page.
Active substance: furosemide
Active substance: ferric citrate coordination complex
Active substance: belzutifan
Active substance: axitinib
Active substance: bevacizumab
Active substance: Gadopiclenol
Active substance: Gadopiclenol
Active substance: vadadustat
Active substance: dapagliflozin
Active substance: sorafenib tosilate
Active substance: bevacizumab
Active substance: difelikefalin
Active substance: finerenone
Active substance: roxadustat
Active substance: azathioprine
Source: European Medicines Agency, Centrally authorised human medicines (EPAR), authorised now. Retrieved 12 Nov 2026.
Countries side by side on public measures for this topic.
Worldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report Public HealthWorldwide · 2024–2034
View report Public HealthWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report Medical DevicesWorldwide · 2024–2034
View reportAcuitas market sizes and forecasts are only in our full reports. How we use public data.